A rare-disease federal incentive program critical to biotech R&D is in jeopardy, writes Leslie Williams, president and CEO of ...

Our process uses bottom-up analysis aimed at identifying what we believe are growing, large-cap companies demonstrating ...

New Haven's biotech sector seeks room to grow even as an industry slowdown results in a major lab space glut in Boston.

Industry insiders hope the Fed’s decision to cut rates for the first time in years will boost biotech investment. But the long-awaited move won’t cure all that ails the sector, others cautioned.

The global biotech giant is making a big bet on the South Philly campus, and says it’ll be hiring locally to fill the jobs.

The interest rate cut expected this week has a potential double impact of opening financial options to emerging growth ...